TY - JOUR
T1 - Protein kinase Cα-responsive polymeric carrier
T2 - Its application for gene delivery into human cancers
AU - Tomiyama, Tetsuro
AU - Kang, Jeong Hun
AU - Toita, Riki
AU - Niidome, Takuro
AU - Katayama, Yoshiki
PY - 2009/7/23
Y1 - 2009/7/23
N2 - For cancer-targeting gene delivery, we applied a protein kinase C (PKC)α-responsive polymeric carrier to human cancers (U-87 MG [human glioblastoma-astrocytoma, epithelial-like cell line]and A549 [human lung adenocarcinoma epithelial cell line]). Two polymers, one a PKCα-responsive polymer (PPC[S]) containing the phosphorylation site serine, and the other a negative control polymer (PPC[A]), in which the serine was substituted with alanine, were synthesized. No cytotoxicity of the polymer was identified. When the complexes were transfected into cancer cells or tissues in which PKCα was hyper-activated, the luciferase expression from the PPC(S)/plasmid (pDNA) complex was higher than that from the PPC(A)/pDNA complex. These results show that the phosphorylation of complex by PKCα in cancer cells leads to high gene expression and that our system can be used as a human cancer cell-targeting gene delivery system.
AB - For cancer-targeting gene delivery, we applied a protein kinase C (PKC)α-responsive polymeric carrier to human cancers (U-87 MG [human glioblastoma-astrocytoma, epithelial-like cell line]and A549 [human lung adenocarcinoma epithelial cell line]). Two polymers, one a PKCα-responsive polymer (PPC[S]) containing the phosphorylation site serine, and the other a negative control polymer (PPC[A]), in which the serine was substituted with alanine, were synthesized. No cytotoxicity of the polymer was identified. When the complexes were transfected into cancer cells or tissues in which PKCα was hyper-activated, the luciferase expression from the PPC(S)/plasmid (pDNA) complex was higher than that from the PPC(A)/pDNA complex. These results show that the phosphorylation of complex by PKCα in cancer cells leads to high gene expression and that our system can be used as a human cancer cell-targeting gene delivery system.
UR - http://www.scopus.com/inward/record.url?scp=67650684000&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=67650684000&partnerID=8YFLogxK
U2 - 10.1111/j.1349-7006.2009.01198.x
DO - 10.1111/j.1349-7006.2009.01198.x
M3 - Article
C2 - 19459855
AN - SCOPUS:67650684000
SN - 1347-9032
VL - 100
SP - 1532
EP - 1536
JO - Cancer Science
JF - Cancer Science
IS - 8
ER -